CD8+ cells immunopurified from healthy donors were differentiated to CTLs [18] and cultured for 48 h in the presence of complete culture medium alone or media conditioned by either healthy B cells or leukemic cells from CLL patients (experimental workflow in Fig. 1A). The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.